(Total Views: 556)
Posted On: 05/26/2022 2:00:57 AM
Post# of 154186
Quote:
there is zero chance Leronlimab has not been continued in the surviving patients in this trial.
Cytodyn may be using either the primary completion date or the study completion date as last date of dosing. Best case scenario - basket trial - March, 2022, mTNBC - September, 2022, compassionate use being a study rather than a trial does not have an end date but they had announced at some point they were shutting it down.
(0)
(0)
